Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs
Public ClinicalTrials.gov record NCT00002240. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of the Safety and Antiviral Efficacy of a Novel HIV-1 Protease Inhibitor, BMS-232632, Alone and in Combination With d4T and ddI as Compared to a Reference Combination Regimen
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate a new protease inhibitor known as BMS-232632. This drug will be given in combination with 2 other anti-HIV drugs (stavudine and didanosine). The effectiveness of BMS-232632 against HIV infection will be compared to that of nelfinavir, a protease inhibitor that is already commonly prescribed.
Study identification
- NCT ID
- NCT00002240
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 1999 (Type not available)
- Primary completion
- Dec 2001 (Actual)
- Completion
- Dec 2001 (Actual)
- Last update posted
- May 4, 2011
1999 – 2001
United States locations
- U.S. sites
- 16
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinsites / Sorra Research Ctr | Birmingham | Alabama | 35203 | — |
| Univ of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| UCSD Treatment Ctr | San Diego | California | 92103 | — |
| UCSF - San Francisco Gen Hosp | San Francisco | California | 94110 | — |
| Univ of Colorado / Health Science Ctr | Denver | Colorado | 80262 | — |
| ViRx / Dupont Circle Physicians Group | Washington D.C. | District of Columbia | 20009 | — |
| AIDS Research Consortium of Atlanta | Atlanta | Georgia | 30308 | — |
| Rush Presbyterian - Saint Luke's Med Ctr | Chicago | Illinois | 60612 | — |
| Washington Univ School of Medicine | St Louis | Missouri | 63108 | — |
| Albany Med College | Albany | New York | 12208 | — |
| Beth Israel Med Ctr | New York | New York | 10003 | — |
| Columbia Presbyterian Med Ctr | New York | New York | 10032 | — |
| Case Western Reserve Univ | Cleveland | Ohio | 44106 | — |
| Oak Lawn Physicians Group | Dallas | Texas | 75219 | — |
| Univ of Texas Southwestern Med Ctr of Dallas | Dallas | Texas | 75235 | — |
| Univ TX Galveston Med Branch | Galveston | Texas | 77555 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002240, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 4, 2011 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00002240 live on ClinicalTrials.gov.